Cite
HARVARD Citation
Zhang, Y. et al. (2021). Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18–59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial. Lancet infectious diseases. 21 (2), pp. 181-192. [Online].